Apricus Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Apricus Wealth's ABBV Position: Q3 2026 in Review
Apricus Wealth reduced its AbbVie (ABBV) stake by 0.15% in Q3 2026, selling an estimated $10.3K and leaving 26,194 shares worth $6.85M. The position accounts for 3.09% of the portfolio, ranked #2.
Apricus Wealth first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Apricus Wealth held 26,194 shares of AbbVie worth $6.85M as of Q3 2026.
- Apricus Wealth sold 40 AbbVie shares in Q3 2026, an estimated $10.3K.
- AbbVie made up 3.09% of Apricus Wealth's portfolio in Q3 2026, its #2 holding.
- Apricus Wealth first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Apricus Wealth's 13F filing for Q3 2026, filed 26 Oct 2026.